GC Aesthetics, a provider of silicone breast implants in Latin America and EMEA, announced terms for its IPO on Monday.
The Dublin, Ireland-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, it would command a fully diluted market value of $260 million.
GC Aesthetics, which was founded in 1979 and booked $55 million in sales for the 12 months ended March 31, 2015, plans to list on the Nasdaq under the symbol GCAA. BofA Merrill Lynch, Deutsche Bank and Cowen & Company are the joint bookrunners on the deal. It is expected to price during the week of August 3, 2015.
